title: Clinical and prognostic features of patients with pandemic 2009 influenza A (H1N1) virus in the intensive care unit.
abstract: OBJECTIVE
  To investigate the clinical and prognostic features of patients admitted to intensive care unit (ICU) with pandemic 2009 influenza A (H1N1) virus.
  
  
  METHODS
  Patients admitted to the intensive care unit for severe pneumonia associated with pandemic 2009 influenza A (H1N1) virus were evaluated.
  
  
  RESULTS
  The study included 20 patients with the mean age of 36±13. Of the 20 subjects, 17 (85%) had underlying conditions. Of the 20 patients, 11(55%) were discharged and 9 (45%) died. Cardinal symptoms were fever, myalgia, and hemoptysis with the rates of 85 %, 75 % and 45 %, respectively. All patients had pneumonic infiltrations in their chest roentgenograms. Main laboratory findings were lymphopenia, high creatin phosphokinase (CPK) and Lactate dehydrogenase (LDH) levels. All patients had positivity on real time reverse transcription-polymerase chain reaction (RT-PCR). None of the patients had pandemic 2009 influenza A (H1N1) virus vaccination. None of them had taken oseltamivir within 48 hours. Main reasons for mortality were cardiovascular complications and ventilatory associated pneumonia due to Acynetobacter baumannii.
  
  
  CONCLUSIONS
  Early diagnosis and antiviral treatment in these cases seem to be the best approach to avoid serious illness. Special attention should be given to patients having underlying conditions such as cardiovascular and pulmonary diseases and pregnancy.
authors.affiliation: Department of Pulmonary and Critical Care, Medical Faculty of Yuzuncu Yil University, Van, Turkye. bunyaminsert@hotmail.com
authors.forename: B
authors.initials: B
authors.lastname: Sertogullarindan
authors.forename: B
authors.initials: B
authors.lastname: Ozbay
authors.forename: H
authors.initials: H
authors.lastname: Gunini
authors.forename: A
authors.initials: A
authors.lastname: Sunnetcioglu
authors.forename: A
authors.initials: A
authors.lastname: Arisoy
authors.forename: H M
authors.initials: HM
authors.lastname: Bilgin
authors.forename: B
authors.initials: B
authors.lastname: Mermit Cilingir
authors.forename: M
authors.initials: M
authors.lastname: Duran
authors.forename: H
authors.initials: H
authors.lastname: Yildiz
authors.forename: S
authors.initials: S
authors.lastname: Ekin
authors.forename: Ai
authors.initials: A
authors.lastname: Baran
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D002423:Cause of Death; D015897:Comorbidity; D005260:Female; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology; D007362:Intensive Care Units / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D009549:Nigeria / Q000453:epidemiology; D053139:Oseltamivir / Q000627:therapeutic use; D058873:Pandemics; D010343:Patient Admission / Q000706:statistics & numerical data; D011024:Pneumonia, Viral / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D011379:Prognosis; D011446:Prospective Studies; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012720:Severity of Illness Index; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir